A detailed history of Northwestern Mutual Wealth Management CO transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 1,137 shares of NBIX stock, worth $142,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,137
Previous 757 50.2%
Holding current value
$142,864
Previous $104,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $43,540 - $58,197
380 Added 50.2%
1,137 $130,000
Q2 2024

Aug 15, 2024

BUY
$130.86 - $143.19 $6,543 - $7,159
50 Added 7.07%
757 $104,000
Q1 2024

May 15, 2024

BUY
$130.4 - $143.74 $782 - $862
6 Added 0.86%
707 $97,000
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $38,927 - $48,722
367 Added 109.88%
701 $92,000
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $4,889 - $6,089
-52 Reduced 13.47%
334 $37,000
Q2 2023

Aug 14, 2023

SELL
$89.53 - $104.87 $3,491 - $4,089
-39 Reduced 9.18%
386 $36,000
Q1 2023

May 15, 2023

SELL
$94.11 - $123.02 $13,645 - $17,837
-145 Reduced 25.44%
425 $43,000
Q4 2022

Feb 21, 2023

SELL
$106.72 - $127.06 $254,313 - $302,783
-2,383 Reduced 80.7%
570 $68,000
Q3 2022

Nov 14, 2022

SELL
$92.03 - $107.81 $4,141 - $4,851
-45 Reduced 1.5%
2,953 $314,000
Q2 2022

Aug 04, 2022

BUY
$75.79 - $100.07 $4,850 - $6,404
64 Added 2.18%
2,998 $292,000
Q1 2022

May 09, 2022

SELL
$72.45 - $94.81 $6,810 - $8,912
-94 Reduced 3.1%
2,934 $275,000
Q4 2021

Feb 03, 2022

BUY
$79.65 - $106.22 $7,805 - $10,409
98 Added 3.34%
3,028 $258,000
Q3 2021

Nov 15, 2021

BUY
$86.18 - $99.03 $4,309 - $4,951
50 Added 1.74%
2,930 $281,000
Q2 2021

Aug 13, 2021

SELL
$89.43 - $102.27 $109,283 - $124,973
-1,222 Reduced 29.79%
2,880 $281,000
Q1 2021

May 14, 2021

BUY
$87.57 - $119.4 $255,091 - $347,812
2,913 Added 245.0%
4,102 $399,000
Q4 2020

Feb 12, 2021

SELL
$86.91 - $108.33 $201,631 - $251,325
-2,320 Reduced 66.12%
1,189 $114,000
Q3 2020

Nov 13, 2020

BUY
$96.16 - $135.15 $174,338 - $245,026
1,813 Added 106.9%
3,509 $337,000
Q2 2020

Aug 14, 2020

BUY
$85.09 - $130.36 $137,590 - $210,792
1,617 Added 2046.84%
1,696 $207,000
Q1 2020

May 08, 2020

BUY
$75.11 - $113.76 $1,276 - $1,933
17 Added 27.42%
79 $7,000
Q4 2019

Feb 13, 2020

BUY
$86.8 - $118.57 $173 - $237
2 Added 3.33%
62 $7,000
Q3 2019

Nov 12, 2019

SELL
$83.82 - $101.5 $2,179 - $2,639
-26 Reduced 30.23%
60 $5,000
Q1 2019

May 10, 2019

SELL
$69.31 - $91.53 $12,059 - $15,926
-174 Reduced 66.92%
86 $7,000
Q4 2018

Feb 12, 2019

BUY
$68.32 - $124.36 $11,204 - $20,395
164 Added 170.83%
260 $19,000
Q2 2018

Aug 10, 2018

SELL
$75.3 - $105.99 $1,129 - $1,589
-15 Reduced 13.51%
96 $9,000
Q1 2018

May 14, 2018

BUY
$75.88 - $92.43 $1,138 - $1,386
15 Added 15.63%
111 $9,000
Q2 2017

Aug 10, 2017

BUY
N/A
96
96 $4,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.